H. Lundbeck, Synaptic Pharmaceutical part of H. Lundbeck A/S

As of today, Synaptic Pharmaceutical Corporation is a wholly owned subsidiary of H. Lundbeck A/S. Lundbeck expects that Synaptic's shares of common stock will be delisted from The Nasdaq Stock Market and will no longer be traded at the close of today’s market.